Dynavax Technologies [DVAX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Dynavax Technologies Corporation

NASDAQ
Loading...

Haleon Plc - ADR

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dynavax Technologies Corporation wins in 7 metrics, Haleon Plc - ADR wins in 13 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dynavax Technologies Corporation Haleon Plc - ADR Better
P/E Ratio (TTM) 54.60 18.72 Haleon Plc - ADR
Price-to-Book Ratio 3.41 1.88 Haleon Plc - ADR
Debt-to-Equity Ratio 54.15 52.37 Haleon Plc - ADR
PEG Ratio 0.71 15.42 Dynavax Technologies Corporation
EV/EBITDA 60.37 33.08 Haleon Plc - ADR
Profit Margin (TTM) -13.13% 15.11% Haleon Plc - ADR
Operating Margin (TTM) 24.77% 23.17% Dynavax Technologies Corporation
EBITDA Margin (TTM) 24.77% 23.17% Dynavax Technologies Corporation
Return on Equity -7.14% 10.27% Haleon Plc - ADR
Return on Assets (TTM) 1.20% 4.67% Haleon Plc - ADR
Free Cash Flow (TTM) $60.16M $2.22B Haleon Plc - ADR
Dividend Yield N/A 1.63% N/A
1-Year Return 20.90% -20.18% Dynavax Technologies Corporation
Price-to-Sales Ratio (TTM) 5.51 3.78 Haleon Plc - ADR
Enterprise Value $1.46B $122.54B Haleon Plc - ADR
EV/Revenue Ratio 4.42 8.23 Dynavax Technologies Corporation
Gross Profit Margin (TTM) 84.82% 55.38% Dynavax Technologies Corporation
Revenue per Share (TTM) $3 $2 Dynavax Technologies Corporation
Earnings per Share (Diluted) $-0.37 $0.50 Haleon Plc - ADR
Beta (Stock Volatility) 0.93 0.33 Haleon Plc - ADR
Short % of Float 13.19% 0.43% Haleon Plc - ADR

Dynavax Technologies Corporation vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

DVAX
HLN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dynavax Technologies Corporation0.00%0.13%-1.15%40.40%47.90%0.78%
Haleon Plc - ADR0.23%-5.84%-5.84%-19.96%-10.03%-13.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dynavax Technologies Corporation20.90%39.64%53.92%-21.40%-49.68%-74.59%
Haleon Plc - ADR-20.18%9.16%22.27%22.27%22.27%22.27%

Performance & Financial Health Analysis: Dynavax Technologies Corporation vs Haleon Plc - ADR

MetricDVAXHLN
Market Information
Market Cap i$1.82B$42.40B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i2,683,4476,594,249
90 Day Avg. Volume i3,501,3197,985,230
Last Close$15.50$8.72
52 Week Range$9.20 - $15.73$8.65 - $11.30
% from 52W High-1.46%-22.83%
All-Time High$106.60 (Nov 27, 2006)$11.42 (Jun 02, 2025)
% from All-Time High-85.46%-23.64%
Growth Metrics
Quarterly Revenue Growth0.18%0.01%
Quarterly Earnings Growth0.53%0.86%
Financial Health
Profit Margin (TTM) i-0.13%0.15%
Operating Margin (TTM) i0.25%0.23%
Return on Equity (TTM) i-0.07%0.10%
Debt to Equity (MRQ) i54.1552.37
Cash & Liquidity
Book Value per Share (MRQ)$4.55$4.99
Cash per Share (MRQ)$5.52$0.15
Operating Cash Flow (TTM) i$90.63M$3.56B
Levered Free Cash Flow (TTM) i$51.30M$1.89B
Dividends
Last 12-Month Dividend Yield iN/A1.63%
Last 12-Month Dividend iN/A$0.17

Valuation & Enterprise Metrics Analysis: Dynavax Technologies Corporation vs Haleon Plc - ADR

MetricDVAX (Feb 27, 2026)HLN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i54.6018.72
Forward P/E i46.9715.42
PEG Ratio i0.7115.42
Price to Sales (TTM) i5.513.78
Price to Book (MRQ) i3.411.88
Market Capitalization
Market Capitalization i$1.82B$42.40B
Enterprise Value i$1.46B$122.54B
Enterprise Value Metrics
Enterprise to Revenue i4.428.23
Enterprise to EBITDA i60.3733.08
Risk & Other Metrics
Beta i0.930.33
Book Value per Share (MRQ) i$4.55$4.99

Financial Statements Comparison: Dynavax Technologies Corporation vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDVAX (2024)HLN (2025)
Revenue/Sales i277.25M11.03B
Cost of Goods Sold i49.45M3.95B
COGS % of Revenue i17.8%35.8%
Gross Profit i227.80M7.08B
Gross Margin i82.2%64.2%
Research & Development i61.55M316.00M
Operating Income (EBIT) i-4.12M2.41B
Operating Margin i-1.5%21.9%
EBITDA i45.70M2.81B
EBITDA Margin i16.5%25.5%
Pre-Tax Income i30.86M2.15B
Pre-Tax Income % of Revenue i11.1%19.5%
Income Tax i3.55M472.00M
Income Tax % of Revenue i1.3%4.3%
Net Income (Profit) i27.31M1.68B
Profit Margin i9.9%15.2%

Balance Sheet & Liquidity Metrics

MetricDVAX (2024)HLN (2025)
Cash & Equivalents i95.88M1.26B
Total Current Assets i848.94M4.55B
Total Current Assets % of Revenue i306.2%41.3%
Total Current Liabilities i78.63M4.93B
Total Current Liabilities % of Revenue i28.4%44.7%
Long-Term Debt i250.24M7.75B
Long-Term Debt % of Revenue i90.3%70.2%
Total Shareholders Equity i596.80M16.48B
Retained Earnings i-903.28M27.85B
Retained Earnings % of Revenue i-325.8%252.5%
Property, Plant & Equipment i39.76M1.00M

Cash Flow Statement Comparison

MetricDVAX (2024)HLN (2025)
Operating Cash Flow i69.99M2.19B
Operating Cash Flow % of Revenue i25.2%19.8%
Capital Expenditures i-6.35M-322.00M
Free Cash Flow i60.16M2.22B
FCF Margin i21.7%20.1%
Debt Repayment iN/A-1.35B
Common Stock Repurchase i-100.00M-654.00M

Short Interest & Institutional Ownership Analysis

MetricDVAXHLN
Shares Short i9.79M19.28M
Short Ratio i2.812.14
Short % of Float i13.19%0.43%
Shares Outstanding i117.36M8.91B
Float Shares i100.34M8.86B
% Held by Insiders i0.75%0.01%
% Held by Institutions i101.55%12.74%
% Held by Public i-2.30%87.25%

Dividend Analysis & Yield Comparison: Dynavax Technologies Corporation vs Haleon Plc - ADR

MetricDVAXHLN
Last 12-Month Dividend iN/A$0.17
Last 12-Month Dividend Yield iN/A1.63%
3-Year Avg Annual Dividend iN/A$0.11
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$0.34
Ex-Dividend DateN/AApr 25, 2025